Page last updated: 2024-09-04

vatalanib and Chronic Pain

vatalanib has been researched along with Chronic Pain in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Li, G; Liang, S; Liu, H; Liu, S; Peng, H; Qiu, S; Tu, G; Xie, J; Xu, C	1

Other Studies

1 other study(ies) available for vatalanib and Chronic Pain

Article	Year
Vatalanib decrease the positive interaction of VEGF receptor-2 and P2X2/3 receptor in chronic constriction injury rats. Neurochemistry international, 2012, Volume: 60, Issue:6 Topics: Animals; Chronic Pain; Disease Models, Animal; Male; Neuralgia; Phthalazines; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X2; Receptors, Purinergic P2X3; Vascular Endothelial Growth Factor Receptor-2	2012

Article

Year

Vatalanib decrease the positive interaction of VEGF receptor-2 and P2X2/3 receptor in chronic constriction injury rats.

Neurochemistry international, 2012, Volume: 60, Issue:6

Topics: Animals; Chronic Pain; Disease Models, Animal; Male; Neuralgia; Phthalazines; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X2; Receptors, Purinergic P2X3; Vascular Endothelial Growth Factor Receptor-2

2012